Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Bibliografiska uppgifter
Huvudupphovsman: Akter, Anika
Övriga upphovsmän: Alam, Marzia
Materialtyp: Lärdomsprov
Språk:English
Publicerad: Brac University 2022
Ämnen:
TNF-alpha
Rheumatoid arthritis
Biologics
Biosimilars
Adalimumab
ABP-501
Pharmacokinetics
Immunogenicity
Plaque psoriasis
Inflammation
Immunity
Länkar:http://hdl.handle.net/10361/17039
Beskrivning
Sammanfattning:This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Liknande verk